Dental Care Clinics in Port Hueneme, CA Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Channel Islands Family Dental Office Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2601 N Ventura Rd, Port Hueneme, CA 93041 Phone: 805-985-6966 Fax: 805-984-6067 |
Dennis L Tank Dds Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 475 W Channel Islands Blvd, 203, Port Hueneme, CA 93041 Phone: 805-985-0300 |
Al Sharif Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 460 E Pleasant Valley Rd, #b, Port Hueneme, CA 93041 Phone: 805-488-1611 Fax: 805-986-9406 |
All Care Dental By The Sea Dentist Medicare: Not Enrolled in Medicare Practice Location: 607 W Channel Islands Blvd, Port Hueneme, CA 93041 Phone: 805-985-2273 Fax: 805-985-2291 |
Landmark Family Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 521 W Channel Islands Blvd Ste 8, Port Hueneme, CA 93041 Phone: 805-815-4356 |
Johnson Family Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 305 E Port Hueneme Rd, Port Hueneme, CA 93041 Phone: 805-488-1112 |
News Archive
A backbone free energy study of SARS-CoV-2 variants of concern
A recent study by scientist Robert Penner at the Institut des Hautes Études Scientifiques in France utilizes free energy calculations to predict effective antiviral targets that are highly conserved, surface-accessible for interaction, and resistant to mutation.
UT Southwestern scientists discover leptin can also aid type 1 diabetics
Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center.
Researchers explore how to optimally control diseases in prison population using rapid tests
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
Taro Pharmaceutical Industries initiates its T2007 non-sedating barbiturate compound Phase I clinical trials
Taro Pharmaceutical Industries Ltd. announced that it has begun Phase I clinical trials in Canada with T2007, the second in the Company's class of proprietary non-sedating barbiturate compounds to be approved for studies in humans.
› Verified 3 days ago